{"title":"宫颈癌免疫治疗:历史性突破击败检查点","authors":"R. Penson","doi":"10.21037/whi.2018.11.01","DOIUrl":null,"url":null,"abstract":"Who benefits from immunotherapy? What constitutes a breakthrough? Where do the blockbuster pharmaceutical come from? When are clinical and scientific dreams realized? Why does getting a drug to market require such a huge, long and costly investment? How do we pick the winners?","PeriodicalId":125517,"journal":{"name":"Women’s Health Investigation","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunotherapy in cervical cancer: historic breakthroughs beating checkpoints\",\"authors\":\"R. Penson\",\"doi\":\"10.21037/whi.2018.11.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Who benefits from immunotherapy? What constitutes a breakthrough? Where do the blockbuster pharmaceutical come from? When are clinical and scientific dreams realized? Why does getting a drug to market require such a huge, long and costly investment? How do we pick the winners?\",\"PeriodicalId\":125517,\"journal\":{\"name\":\"Women’s Health Investigation\",\"volume\":\"40 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Women’s Health Investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/whi.2018.11.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Women’s Health Investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/whi.2018.11.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Immunotherapy in cervical cancer: historic breakthroughs beating checkpoints
Who benefits from immunotherapy? What constitutes a breakthrough? Where do the blockbuster pharmaceutical come from? When are clinical and scientific dreams realized? Why does getting a drug to market require such a huge, long and costly investment? How do we pick the winners?
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
